1. Home
  2. HCM vs LSBPW Comparison

HCM vs LSBPW Comparison

Compare HCM & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • LSBPW
  • Stock Information
  • Founded
  • HCM 2000
  • LSBPW N/A
  • Country
  • HCM Hong Kong
  • LSBPW China
  • Employees
  • HCM N/A
  • LSBPW 758
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCM Health Care
  • LSBPW Health Care
  • Exchange
  • HCM Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • HCM N/A
  • LSBPW N/A
  • IPO Year
  • HCM N/A
  • LSBPW N/A
  • Fundamental
  • Price
  • HCM $16.74
  • LSBPW $0.04
  • Analyst Decision
  • HCM Buy
  • LSBPW
  • Analyst Count
  • HCM 2
  • LSBPW 0
  • Target Price
  • HCM $20.55
  • LSBPW N/A
  • AVG Volume (30 Days)
  • HCM 80.2K
  • LSBPW N/A
  • Earning Date
  • HCM 07-31-2024
  • LSBPW N/A
  • Dividend Yield
  • HCM N/A
  • LSBPW N/A
  • EPS Growth
  • HCM N/A
  • LSBPW N/A
  • EPS
  • HCM N/A
  • LSBPW N/A
  • Revenue
  • HCM $610,806,000.00
  • LSBPW N/A
  • Revenue This Year
  • HCM N/A
  • LSBPW N/A
  • Revenue Next Year
  • HCM $21.06
  • LSBPW N/A
  • P/E Ratio
  • HCM N/A
  • LSBPW N/A
  • Revenue Growth
  • HCM N/A
  • LSBPW N/A
  • 52 Week Low
  • HCM $11.93
  • LSBPW N/A
  • 52 Week High
  • HCM $21.92
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • HCM 33.83
  • LSBPW N/A
  • Support Level
  • HCM $18.24
  • LSBPW N/A
  • Resistance Level
  • HCM $18.81
  • LSBPW N/A
  • Average True Range (ATR)
  • HCM 0.46
  • LSBPW 0.00
  • MACD
  • HCM -0.29
  • LSBPW 0.00
  • Stochastic Oscillator
  • HCM 4.03
  • LSBPW 0.00

About LSBPW LakeShore Biopharma Co. Ltd

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: